N-domain-specific substrate and c-domain inhibitors of angiotensin- converting enzyme angiotensin-(1-7) and keto-ace

Hypertension

Volumn 31, Issue 4, 1998, Pages 912-917

  Deddish, Peter A ^a   Marcic, Branislav ^a   Jackman, Herbert L ^a   Wang, Huan Zhu ^a   Skidgel, Randal A ^a   Erdös, Ervin G ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Arachidonic acid; Bradykinin; Enzymes; Receptors; Signal transduction

Indexed keywords

ANGIOTENSIN; ARACHIDONIC ACID; BRADYKININ; DIPEPTIDYL CARBOXYPEPTIDASE;

ARTICLE; CHO CELL; ENZYME ASSAY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; SEQUENCE ANALYSIS;

EID: 0031954590     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.31.4.912     Document Type: Article

References (42)

1. Welches WR, Brosnihan KB, Ferrario CM. A comparison of the properties and enzymatic activities of three angiotensin processing enzymes: angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase 24.11. Life Sci. 1993;52:1461-1480.
2. Gafford JT, Skidgel RA, Erdös EG, Hersh LB. Human kidney "enkephalinase," a neutral metalloendopeptidase that cleaves active peptides. Biochemistry. 1983;22:3265-3271.
3. Chappell MC, Tallant EA, Brosnihan KB, Ferrario CM. Conversion of angiotensin I to angiotensin-(1-7) by thimet oligopeptidase (EC 3.4.24.15) in vascular smooth muscle cells. J Vasc Med Biol. 1994;5: 129-137.
4. Santos RAS, Brosnihan KB, Jacobsen DW, DiCorleto PE, Ferrario CM. Production of angiotensin-(1-7) by human vascular endothelium. Hypertension. 1992;19(suppl II):II-56-II-61.
5. Tan F, Morris PW, Skidgel RA, Erdös EG. Sequencing and cloning of human prolylcarboxypeptidase (angiotensinase C): similarity to both serine carboxypeptidase and prolylendopeptidase families. J Biol Chem. 1993;268:16631-16638.
6. Ferrario CM, Barnes KL, Block CH, Brosnihan KB, Diz DI, Khosla MC, Santos RAS. Pathways of angiotensin formation and function in the brain. Hypertension. 1990;15(suppl I):I-13-I-19.
7. Brosnihan KB, Li P, Ferrario CM. Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension. 1996; 27(part 2):523-528.
8. Schiavone MT, Santos RAS, Brosnihan KB, Khosla MC, Ferrario CM. Release of vasopressin from the rat hypothalamo-neurohypophysial system by angiotensin-(1-7) heptapeptide. Proc Natl Acad Sci U S A. 1988;85:4095-4098.
9. Li P, Chappell MC, Ferrario CM, Brosnihan KB. Angiotensin-(1-7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide. Hypertension. 1997;29(part 2):394-400.
10. Fontes MAP, Silva LCS, Campagnole-Santos MJ, Khosla MC, Guertzenstein PG, Santos RAS. Evidence that angiotensin-(1-7) plays a role in the central control of blood pressure at the ventro-lateral medulla acting through specific receptors. Brain Res. 1994;665:175-180.
11. Diz DI, Pirro NT. Differential actions of angiotensin II and angiotensin-(1-7) on transmitter release. Hypertension. 1992;19(suppl II):II-41-11-48.
12. Tallant EA, Lu X, Weiss RB, Chappell MC, Ferrario CM. Bovine aortic endothelial cells contain an angiotensin-(1-7) receptor. Hypertension. 1997;29(part 2):388-393.
13. Pörsti I, Bara AT, Busse R, Hecker M. Release of nitric oxide by angiotensin-(1-7) from porcine coronary endothelium: implications for a novel angiotensin receptor. Br J Pharmacol. 1994;111:652-654.
14. Abbas A, Gorelik G, Carbini LA, Scicli AG. Angiotensin-(1-7) induces bradykinin-mediated hypotensive responses in anesthetized rats. Hypertension. 1997;30(part 1):217-221.
15. Skidgel RA, Erdös EG. Biochemistry of angiotensin converting enzyme. In: Robertson JIS, Nicholls MG, eds. The Renin Angiotensin System. London, England: Gower Medical Publishing; 1993:10.1-10.10.
16. Ondetti MA. From peptides to peptidases: a chronicle of drug discovery. Ann Rev Pharmacol. 1994;34:1-16.
17. Patchett AA, Cordes EH. The design and properties of N-carboxyalkyldipeptide inhibitors of angiotensin converting enzyme. Adv Enzymol Relat Areas Mol Biol. 1985;57:1-84.
18. Gavras H. Angiotensin converting enzyme inhibition and the heart. Hypertension. 1994;23:813-818.
19. Soubrier F, Alhenc-Gelas F, Hubert C, Allegrini J, John M, Gregear G, Corvol P. Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc Natl Acad Sci U S A. 1988; 85:9386-9390.
20. Bernstein KE, Martin BM, Edwards AS, Bernstein EA. Mouse angiotensin-converting enzyme is a protein composed of two homologous domains. J Biol Chem. 1989;264:11945-11951.
21. Wei L, Alhenc-Gelas F, Corvol P, Clauser E. The two homologous domains of human angiotensin I-converting enzyme are both catalytically active. J Biol Chem. 1991;266:9002-9008.
22. Erdös EG, Gafford JT. Human converting enzyme. Clin Exp Hypertens. 1983;A5:1251-1262.
23. Soubrier F, Hubert C, Testut P, Nadaud S, Alhenc-Gelas F, Corvol P. Molecular biology of the angiotensin I converting enzyme, I: biochemistry and structure of the gene. J Hypertens. 1993;11:471-476.
24. Soubrier F, Wei L, Hubert C, Clauser E, Alhenc-Gelas F, Corvol P. Molecular biology of the angiotensin I converting enzyme, II: structure-function: gene polymorphism and clinical implications. J Hypertens. 1993;11:599-604.
25. Kumar RS, Kusari J, Roy SN, Soffer RL, Sen GC. Structure of testicular angiotensin-converting enzyme: a segmental mosaic enzyme. J Biol Chem. 1989;264:16754-16758.
26. Kumar RS, Thekkumkara TJ, Sen GC. The mRNAs encoding the two angiotensin converting isozymes are transcribed from the same gene by a tissue-specific choice of alternative transcription initiation sites. J Biol Chem. 1991;266:3854-3862.
27. Ehlers MRW, Fox EA, Strydom DJ, Riordan JF. Molecular cloning of human testicular angiotensin-converting enzyme: the testis isozyme is identical to the C-terminal half of endothehal angiotensin-converting enzyme. Proc Natl Acad Sci U S A. 1989;86:7741-7745.
28. Weare JA, Stewart TA, Gafford JT, Erdös EG. Inhibition of human converting enzyme in vitro by a novel tripeptide analog. Hypertension. 1981;3(suppl I):I-50-I-53.
29. Minshall RD, Tan F, Nakamura F, Rabito SF, Becker RP, Marcic B, Erdös EG. Potentiation of the actions of bradykinin by angiotensin I converting enzyme (ACE) inhibitors: the role of expressed human bradykinin B2 receptors and ACE in CHO cells. Circ Res. 1997;81: 848-856.
30. Minshall RD, Erdös EG, Vogel SM. Angiotensin I converting enzyme inhibitors potentiate bradykinin's inotropic effects independently of blocking its inactivation. Am J Cardiol. 1997;80:132-136.
31. Deddish PA, Wang J, Michel B, Morris PW, Davidson NO, Skidgel RA, Erdös EG. Naturally occurring active N-domain of human angiotensin I converting enzyme. Proc Natl Acad Sci U S A. 1994;91:7807-7811.
32. Deddish PA, Wang L-X, Jackman HL, Michel B, Wang J, Skidgel RA, Erdös EG. Single-domain angiotensin I converting enzyme (kininase II): characterization and properties. J Pharmacol Exp Ther. 1996;279: 1582-1589.
33. Dantlov S, Jaspard E, Churakova T, Towbin H, Savoie F, Wei L, Alhenc-Gelas F. Structure-function analysis of angiotensin I-converting enzyme using monoclonal antibodies: selective inhibition of the amino-terminal active sites. J Biol Chem. 1994;269:26806-26814.
34. Dixon M, Webb EC. Enzyme inhibition and activation. In: Enzymes. 3rd ed. New York, NY: Academic Press, Inc; 1979:334.
35. Ramchandran R, Sen GC, Misono K, Sen I. Regulated cleavage-secretion of the membrane-bound angiotensin converting enzyme. J Biol Chem. 1994;269:2125-2130.
36. Lattion A-L, Soubrier F, Allegrini J, Hubert C, Corvol P, Alhenc-Gelas F. The testicular transcript of the angiotensin I-converting enzyme encodes for the ancestral, non-duplicated form of the enzyme. FEBS Lett. 1989; 252:99-104.
37. Wei L, Clauser E, Alhenc-Gelas F, Corvol P. The two homologous domains of human angiotensin I-convening enzyme interact differently with competitive inhibitors. J Biol Chem. 1992;267:13398-13405.
38. Perich RB, Jackson B, Johnston CI. Structural constraints of inhibitors for binding at two active sites on somatic angiotensin converting enzyme. Eur J Pharmacol. 1994;266:201-211.
39. Azizi M, Rousseau A, Ezan E, Guyene T-T, Michelet S, Grognet J-M, Lenfant M, Corvol P, Menard J. Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem-cell regulator N-Acetyl-Seryl-Aspartyl-Lysyl-Proline. J Clin Invest. 1996;97:839-844.
40. Erdös EG. News about ACE, or, the separate lives of "Siamese Twin" domains. J Clin Invest. 1996;97:588.
41. Almquist RG, Chao W-R, Ellis ME, Johnson HL. Synthesis and biological activity of a ketomethylene analogue of a tripeptide inhibitor of angiotensin converting enzyme. J Med Chem. 1980;23:1392-1398.
42. Brooks RR, Miller KE, Jones SM, Burns RH, Huang C-T. Selectivity of converting-enzyme inhibitors for angiotensin I versus bradykinin hydrolysis reactions. J Pharm Sci. 1990;79:384-388.